MEDGANA, UAB - financials and debts

Company age: 32 y. 4 mo.

Update

MEDGANA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,537,368 4,214,602 3,852,681 5,319,304 5,767,474 4,386,298 3,992,543 4,255,295
Profit before tax 205,835 326,603 430,186 402,170 69,007 18,380 -41,117 26,122
Net profit 174,834 278,323 365,991 340,882 58,672 14,370 -41,117 24,711
Equity 684,258 962,790 1,269,114 1,486,467 1,498,081 1,512,451 1,471,375 1,496,086
Liabilities 718,228 438,229 322,384 299,990 2,518,094 2,196,552 1,698,222 1,513,862
Non-current assets 73,271 121,406 115,544 111,798 1,899,607 1,916,880 1,793,831 1,729,872
Current assets 1,325,940 1,274,808 1,468,351 1,591,766 2,111,075 1,767,979 1,371,451 1,294,360
Total assets 1,399,211 1,396,214 1,583,895 1,703,564 4,010,682 3,684,859 3,165,282 3,024,232
Taxes paid
STI taxes - - - - - 614,271 634,237 537,439
Social insurance contributions - - - - - 71,891 68,327 73,922
Financial indicators
Revenue change y/y -2.4% +66.1% -8.6% +38.1% +8.4% -23.9% -9.0% +6.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 12.5% 19.9% 23.1% 20.0% 1.5% 0.4% -1.3% 0.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 25.6% 28.9% 28.8% 22.9% 3.9% 1.0% -2.8% 1.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 6.9% 6.6% 9.5% 6.4% 1.0% 0.3% -1.0% 0.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 8.1% 7.7% 11.2% 7.6% 1.2% 0.4% -1.0% 0.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 1.0 0.5 0.3 0.2 1.7 1.5 1.2 1.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 461,340 732,974 660,463 788,045 623,511 442,314 443,616 425,530

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

MEDGANA - Social security debts

From To Debt, €
2026-01-21 2026-01-25 6831.99
2026-01-16 2026-01-20 6830.35

MEDGANA - VMI tax arrears

From To Overdue, €
2026-07-26 2026-07-26 39.0
2026-04-24 2026-04-27 7.09
2026-04-22 2026-04-23 6.68
2026-04-08 2026-04-08 160.63
2026-04-02 2026-04-07 154.0
2026-03-02 2026-03-02 1473.09
2026-01-30 2026-02-16 0.01
2026-01-29 2026-01-29 15978.69
2026-01-08 2026-01-28 0.01
2026-01-02 2026-01-07 36.81
2026-01-01 2026-01-01 35.57
2025-10-30 2025-11-25 3.81
2025-09-22 2025-09-25 0.38
2025-07-01 2025-07-25 0.06
2025-03-28 2025-03-30 9004.86
2025-02-23 2025-02-25 7.45
2025-02-20 2025-02-22 7.0
2025-02-15 2025-02-18 7.0
2024-12-31 2025-01-15 0.66
2024-12-30 2024-12-30 810.52
2024-11-28 2024-11-28 5999.51

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
MEDGANA, UAB (code 122641141) is a Private Limited Liability Company engaged in the wholesale of hardware, plumbing and heating equipment and supplies. In the latest financial year 2025, the company generated revenue of €4.26M, up 6.6% year on year from €3.99M in 2024, but still below €4.39M in 2023. Net profit improved to €24.7K in 2025 after a loss of €41.1K in 2024, following a profit of €14.4K in 2023, which resulted in a 0.6% profit margin. The three-year trend shows a revenue dip in 2024 and recovery in 2025, while profitability moved from positive to negative and back to positive. Total assets declined from €3.68M in 2023 to €3.02M in 2025. Equity remained broadly stable at around €1.5M, while liabilities decreased from €2.20M to €1.51M over the same period. Latest ratios indicate ROE of 1.6%, ROA of 0.8%, debt-to-equity of 1.01, and asset turnover of 1.41x. Revenue per employee reached €425.5K in 2025, with profit per employee of €2.5K.